Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Claudin 18.2 as a New Biomarker in Gastric Cancer—What Should We Know?
Frontiers | Targeting CLDN18.2 in cancers of the gastrointestinal tract ...
Claudin-18.2靶向药物|CLDN18.2靶向药物——药研档案
Research Progress of CLDN18.2 Protein in the Treatment of Malignant ...
Claudin18.2 as a Promising Therapeutic Target in Gastric Cancer
CLDN18.2 CAR-T离突破实体瘤越来越近丨胃癌纳入突破疗法！ - 知乎
CLDN18.2丨肿瘤免疫治疗赛道的黑马 - 知乎
文献分享：胃癌和胰腺癌靶点CLDN18.2
Evolution of claudin18.2 therapies in gastroesophageal cancers | Nature ...
Targeting Claudin18.2 for cancer theranostics: From molecular imaging ...
Development of a Novel CLDN18.2-directed Monoclonal Antibody and ...
自然子刊丨治疗新靶点CLDN18.2综述 - 知乎
What Is CLDN18.2? | CLDN18.2 Pathology Hub
CLDN18.2丨肿瘤免疫治疗赛道的黑马
同行分享|CLDN18.2 靶点介绍
荣昌生物CLDN18.2 ADC I期显示出良好安全性与耐受性 - 知乎
靶向CLDN18.2的抗体偶联(ADC)药物ATG-022治疗胃癌达到90%疾病控制率,一举拿下突破性疗法认定-无癌家园
Frontiers | Pan-cancer analysis of CLDN18.2 shed new insights on the ...
Claudin-18：肿瘤学的治疗靶点 - 每日生物评论
CLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor ...
Claudin 18.2 for solid tumors - Advanced Medicine In China
CLDN18.2 BiTE Engages Effector and Regulatory T Cells for Antitumor ...
Claudin18.who? Examining biomarker overlap and outcomes in claudin18.2 ...
Human CLDN18.2-Strep full length protein-PeptiNanodisc-Full-length ...
德琪医药布局CLDN18.2 ADC：针对CLDN18.2低表达有效，抗体细节在ADC开发中不容忽视_凤凰网
胃癌市场趋势分析：信达、康方、恒瑞等企业竞逐，CLDN18.2靶点成新热点_治疗_药物_Claudin
Human CLDN18.2-Strep full length protein-synthetic nanodisc-全长CLDN18.2 ...
Claudin-18.2 Immunohistochemical Evaluation in Gastric and ...
CLDN18.2 bispecifics available to license
Claudins靶点梳理 - 知乎
Expression of the membrane tetraspanin claudin 18 on cancer cells ...
Recommendation of antibodies: 2023 CSCO guidelines add detection target ...
Preclinical Studies of TAC01-CLDN18.2, an Autologous Claudin 18.2 ...
2023ESMO｜Osemitamab有望改写晚期胃癌CLDN18.2阳性治疗新格局_财富号_东方财富网
Human CLDN18.2 full length protein-VLP-Full-length CLDN18.2 Protein ...
Claudin18.2 expression and clinicopathological features in cytology ...
Profiling of CLDN18.1and CLDN18.2 transcripts in a panel of human ...
Claudin18.2,胃癌患者必须知道的明星靶点,Claudin18.2(CLDN18.2)靶向药胃癌抗癌路上的精准武器_全球肿瘤医生网
再鼎医药CLDN18.2单抗在国内申报临床 12月30日，CDE官网显示， 再鼎医药 CLDN18.2（Claudin18.2）单抗ZL ...
Human CLDN18.2 full length protein-synthetic nanodisc-Full-length ...
ADC药物全球分析 | CLDN18.2靶点 - 知乎
Development and comparison of 68Ga/18F/64Cu-labeled nanobody tracers ...
CLDN18.2 | Advancing Gastric Cancer Diagnosis and Treatment
肿瘤免疫靶点 | Claudin18.2 - 知乎
Screening, Construction, and Preliminary Evaluation of CLDN18.2 ...
6款国产靶向Claudin18.2(CLDN18.2)靶点的药物获批临床引发热潮,更多的Claudin18.2临床试验招募正在进行中_全球肿瘤医生网
CLDN18.2_全部靶点_靶点_全球肿瘤医生网
OncoWuXi速递 | CLDN18.2基因工程细胞系 - 知乎
The role of CLDN18.2 in gastric cancer prognosis: a systematic review ...
(PDF) CLDN18.2 and 4-1BB bispecific antibody givastomig exerts ...
ASCO靶点追踪丨创胜公布CLDN18.2两项研究，对垒安斯泰来？ - 知乎
A CLDN18.2‐Targeted Nanoplatform Manipulates Magnetic Hyperthermia ...
CLDN18.2 overall expression intensity. a 278 of 481 gastric carcinomas ...
超 15 亿美元出海，这款国产 CLDN18.2 ADC 首次启动 III 期临床
The anti-CLDN18.2 ADC and anti-CLDN18.2 CD3 Bispecific inhibit growth ...
Claudin18.2“胸怀大志”的靶点 - 知乎
用于评价肿瘤靶向CLDN18.2治疗药物疗效及生存预测的标志物及其应用
Immunohistochemistry of tumor tissues with CLDN18.2 antibodies. A ...
创新药靶点系列研究之四：CLDN18.2：多技术开花，胃癌治疗潜力大 - 行业研究报告 - 小牛行研
CLDN18.2 Positive & Negative FFPE Tissue Samples | Discovery Life Sciences
NUGC4-CLDN18.2 Cell Line - Kyinno Bio
首个CLDN18.2/4-1BB双抗公布临床数据，天境、创胜、康诺亚等药企持续发力角逐CLDN18.2赛道 去年11月，CLDN18.2赛道 ...
Claudin18.2ADC赛道群雄逐鹿：3家率先进入III期临床 - 知乎
CLDN18.2靶向药获批上市，华大基因为胃癌治疗新星靶点提供高质量检测医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
The impact of CLDN18.2 expression on effector cells mediating antibody ...
Fluorescent Human CLDN18.2 Full Length Protein-VLP (EGFP)-Full-length ...
CLDN18.2, hFc, Human - 金斯瑞生物科技有限公司
The past and present of CLDN18.2 - iNEWS
用于治疗表达CLDN18.2的实体瘤的CLDN18.2/CD3双特异性抗体的制作方法
Claudin 18.2 | VYLOY® (zolbetuximab-clzb)
CLDN18.2 | Homepage
胃癌市场趋势：CLDN18.2靶点药物研发加速，信达、康方、恒瑞...竞相布局_财富号_东方财富网
Recombinant Human CLDN18.2, Validated Activity- CUSABIO
信达差异化布局CLDN18.2 ADC和双抗，胰腺癌等瘤种最新进展汇总_患者_治疗_Claudin
CLDN18.2的前世今生（3）-CLDN18.2药物横空出世 - 知乎
Biotinylated Human CLDN18.2 full length protein-synthetic nanodisc-Full ...
报告封面
Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the ...
Claudin 18.2 Proteins & Stable Cell Lines | GenScript
Claudin 18.2: a new therapeutic target: What are the implications for ...
首款CLDN18.2靶向药有望上市！国内多款药物获批临床，80%胃癌患者可能获益！ - 知乎
Claudins and Gastric Cancer: An Overview
CLDN18.2 monoclonal antibody approved, summarizing the progress of ADC ...
文献分享：胃癌和胰腺癌靶点CLDN18.2|CLDN|细胞|靶向|肿瘤|治疗|-健康界
CLDN18.2：从单抗、ADC 到 CAR-T，这篇文章讲透了！_腾讯新闻
首个CLDN18.2靶向疗法VYLOY一线治疗胃癌在日本获得全球首批-上市-医保-临床适应症-香港济民药业
Distinct clinicopathological and survival profiles of CLDN18.2 and PD ...
-TEM1.jpg)
